Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. - Wikidata - awgldk - TriplyDB

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.

http://www.wikidata.org/entity/Q44705401

about

Integrated disease management interventions for patients with chronic obstructive pulmonary disease Integrated disease management interventions for patients with chronic obstructive pulmonary disease Adiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD)Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease Reproducibility and respiratory function correlates of exhaled breath fingerprint in chronic obstructive pulmonary disease The nasal septum deviation index (NSDI) based on CBCT data.Correlates of COPD and chronic bronchitis in nonsmokers: data from a cross-sectional study.Clinical implications of chronic heart failure phenotypes defined by cluster analysis.Derivation and validation of clinical phenotypes for COPD: a systematic review.Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine.The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.Tiotropium might improve survival in subjects with COPD at high risk of mortality.Characterisation of COPD heterogeneity in the ECLIPSE cohort Multidimensional analyses to assess the relations between treatment choices by physicians and patients' characteristics: the example of COPD.Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene.Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease.Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study feasibility Effect of genome and environment on metabolic and inflammatory profiles Use of cluster analysis to describe desaturator phenotypes in COPD: correlations between pulmonary function tests and nocturnal oxygen desaturation Chronic obstructive pulmonary disease prevalence in Lebanon: a cross-sectional descriptive study.Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.Characterization of Rhinitis According to the Asthma Status in Adults Using an Unsupervised Approach in the EGEA Study.Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease.Clinical Implications of Cluster Analysis-Based Classification of Acute Decompensated Heart Failure and Correlation with Bedside Hemodynamic Profiles.Chronic Obstructive Pulmonary Disease Subtypes. Transitions over Time.Discretization of continuous features in clinical datasets.Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis.A Systemic Inflammatory Endotype of Asthma With More Severe Disease Identified by Unbiased Clustering of the Serum Cytokine Profile.Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.Classification and characterization of class III malocclusion in Chinese individuals.Impact of gender on COPD expression in a real-life cohort.Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities.Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema.Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine.Multidimensional prognostic indices for use in COPD patient care. A systematic review.Phenotyping the heterogeneity of chronic obstructive pulmonary disease.

P2860

Q24197521-EC0C04E7-DC58-44D0-91B6-BCBFB790DA43 Q24235517-406F7886-FD77-402A-A377-F4FDB324C95E Q28390687-2CF0932C-EF30-497D-AD7D-1D4DC704627C Q28392443-FDD6EC69-1DDC-4474-8A15-DE3A207B5D3E Q28484411-257AC108-16F4-416D-90E6-8248EEDD7C3E Q30364422-F9046F81-68A7-4767-9249-4BC91F721135 Q30572996-C9CC34CA-B20E-4DF7-AE86-ACBE390F24C6 Q30604593-65925436-252B-460E-915B-4FB87CEAA30E Q30653887-11782564-6B49-442C-9EB4-70EE8F4D8784 Q30664694-C2E5CB2A-15D4-4844-9C8C-C3B5D2921073 Q30701622-51D66A76-DDDC-40B9-AAC4-ADD652A1F602 Q30925905-DB29B870-999C-423D-91BA-FEA6F63524A2 Q33707570-E551F0DB-9FC8-4004-9C33-16F290FA962F Q33769268-FB8E6A9F-8859-4A69-8ADD-99460C9B39BC Q34149510-92355C3D-7EFA-48A7-A1ED-0B1A42591E3B Q34367792-7EC4A0E1-7D01-440F-BAFA-0898F394A4F8 Q34510698-41A52DE0-59F4-4D60-B6D2-BFA557624986 Q34547587-75F24D37-DA83-4F12-AAEB-E1BFAF91C363 Q34619853-6CDF8128-08CD-4065-A53E-AAFD9280E80E Q34808077-29DAF644-3199-4969-AFB6-A996A4A5E839 Q35091052-97FDE07B-E56B-41BD-85EB-BFCFCC22D9F5 Q35325431-E8F98700-CFE7-4A5E-BA09-347BEA34D7A6 Q35574530-43069D18-D4E8-4083-9455-51BD9C0A3894 Q35671556-2E0D8A20-436C-4DD8-A112-07E29D16D643 Q35675040-63DF011C-0872-4392-920C-CDFE3C85B355 Q35756135-4E06F95D-0F1D-4B9B-9846-B68033D727CD Q35766362-33077616-2C3E-4AD0-805C-962AE1AB8A69 Q35913203-D7DA8F57-20EF-46CD-A604-4A7ED12BC78B Q36128437-02FE6739-48F4-421D-AAF7-95347F4F8528 Q36771106-D719636E-AB9F-4510-9CD4-65AE7350F129 Q36809938-2FEEA940-E34F-4FCE-8A75-A9D1B8FE0EF9 Q37205073-6536C541-85A6-440E-946F-B42E5DD7C900 Q37323319-0B8E415D-26E5-4805-BCCA-15D603DA5AA9 Q37400728-68E95888-E6F6-400E-9FA3-B4021418043D Q37597898-CAF98BDA-FD94-491C-B239-EB38F33C2A23 Q37602455-C36C3894-1948-4DFA-8A9B-F192B0EC275C Q37731708-4ED76A86-E5B4-4119-AAF8-DD4A47A64043 Q37822219-6632A516-2FDB-4037-BA5A-82CA5033D05D Q37955912-0304A384-6286-482B-B57D-1B3492D5C59F Q38063326-4C7886D1-BAC5-4A9F-AF2E-7E4DE8C76E8E

P2860

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.

http://www.wikidata.org/entity/Q44705401

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Clinical COPD phenotypes: a no ...... omponent and cluster analyses.

@en

Clinical COPD phenotypes: a no ...... omponent and cluster analyses.

@nl

type

label

Clinical COPD phenotypes: a no ...... omponent and cluster analyses.

@en

Clinical COPD phenotypes: a no ...... omponent and cluster analyses.

@nl

prefLabel

Clinical COPD phenotypes: a no ...... omponent and cluster analyses.

@en

Clinical COPD phenotypes: a no ...... omponent and cluster analyses.

@nl

P1433

Q44705401-DB46D245-3294-446E-A946-529881807259

P1476

Q44705401-CB884425-63B9-4FEB-A049-536CA03481A1

P2093

Q44705401-03CC7E16-80CA-4361-8875-E89023A78B83

Q44705401-2722A42F-1408-4D21-8449-D47A3913E2F5

Q44705401-3CB5F58F-D552-4997-B41B-51AEAA328C6F

Q44705401-4007C1B2-AF55-4874-A504-161431FBCB85

Q44705401-46B886B8-7ECB-4DB3-A4AA-360E9C979B51

Q44705401-8690D2EC-0A76-43B7-94DC-F618D4BC3A1B

Q44705401-8F9FA0A0-765B-47C8-8F29-C11751391501

Q44705401-9B9DFD35-51CC-4587-8083-B93BBA5F75D8

Q44705401-9F639D6E-622B-4AE7-8563-EF97764899A2

Q44705401-DC34ED86-5AD7-4CB1-B3F1-F425376D7F0D

P304

Q44705401-F1562579-B659-4029-95CB-B915071E90B8

P31

Q44705401-E38E2BCC-537C-4D1F-9DD6-E33D871D567E

P356

Q44705401-36C25B7A-DF59-4372-BBED-B7D3BD328BF7

P433

Q44705401-E4E13C81-7204-4000-A9C7-BD57FCC88C42

P478

Q44705401-E4911DA3-AF2C-4C34-AB39-1D52686808EC

P577

Q44705401-9B2F78A1-52E2-4238-9D9E-FC8C4E0999CC

P5875

Q44705401-2BCA4CD1-37B8-4516-974C-26554862CF5E

P698

Q44705401-9F97FA8C-FA52-4BD1-952B-ADAF04F4D6AF

P921

Q44705401-C3497FDC-C0DB-4778-8965-00CAB470CBD0

P356

09031936.00175109

P1433

European Respiratory Journal

P1476

Clinical COPD phenotypes: a no ...... omponent and cluster analyses.

@en

P2093

D Caillaud

http://www.w3.org/2001/XMLSchema#string

I Court-Fortune

http://www.w3.org/2001/XMLSchema#string

I Tillie-Leblond

http://www.w3.org/2001/XMLSchema#string

Initiatives BPCO Scientific Committee

http://www.w3.org/2001/XMLSchema#string

J-L Paillasseur

http://www.w3.org/2001/XMLSchema#string

N Roche

http://www.w3.org/2001/XMLSchema#string

P Carré

http://www.w3.org/2001/XMLSchema#string

P Chanez

http://www.w3.org/2001/XMLSchema#string

P-R Burgel

http://www.w3.org/2001/XMLSchema#string

R Escamilla

http://www.w3.org/2001/XMLSchema#string

P304

531-539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.00175109

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41028096

http://www.w3.org/2001/XMLSchema#string

P698

20075045

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease